Ignite Creation Date:
2024-05-05 @ 7:30 PM
Last Modification Date:
2024-10-26 @ 9:49 AM
Study NCT ID:
NCT00682552
Status:
TERMINATED
Last Update Posted:
2014-08-28
First Post:
2008-05-19
Brief Title:
Evaluation of Initial High Risk Human Papillomavirus HR-HPV Viral Load as Predictive Marker for Cervical Intraepithelial Neoplasia Grade 1 CIN1 Persistence
Sponsor:
Assistance Publique Hopitaux De Marseille
Organization:
Assistance Publique Hopitaux De Marseille
Study Overview
Official Title:
Evaluation of Initial High Risk Human Papillomavirus HR-HPV Viral Load as Predictive Marker for Cervical Intraepithelial Neoplasia Grade 1 CIN1 Persistence
Status:
TERMINATED
Status Verified Date:
2014-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Relationship between HPV infection and cervical cancer is well established Among the HPV types identified to date 15 are classified as high risk HPV HR-HPV Detection of HR-HPV has been proposed to optimize cervical cancer screening
Detailed Description:
A prospective detection and quantification of HR-HPV in patients with proven CIN1 will be performed Relationship between HR-HPV initial viral load and the CIN1 persistence will be evaluated
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2007-31 | None | None | None |